Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:01812923n
Noun Concept
Categories: Cyclopentanes, Experimental cancer drugs, Drugs not assigned an ATC code, Tyrosine kinase inhibitors
EN
apatinib  N-[4-(1-cyanocyclopentyl)phenyl]-2-[(4-methylpyridin-3-yl)amino]pyridine-3-carboxamidemesylate  C24H23N5O  C25H27N5O3S  N-[4-(1-cyanocyclopentyl)phenyl]-2-[(4-methylpyridin-3-yl)amino]pyridine-3-carboxamide methanesulfonate
EN
Apatinib, also known as Rivoceranib, is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2. Wikipedia
Definitions
Relations
Sources
EN
Apatinib, also known as Rivoceranib, is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2. Wikipedia
IS A
compound
medicine
SUBJECT HAS ROLE
protein kinase inhibitor
antineoplastic
Wikipedia
EN
apatinib
Wikidata
EN
apatinib, N-[4-(1-cyanocyclopentyl)phenyl]-2-[(4-methylpyridin-3-yl)amino]pyridine-3-carboxamidemesylate
Wikipedia Redirections
EN
C24H23N5O, C25H27N5O3S, rivoceranib
Wikidata Alias
EN
rivoceranib, YN968D1, N-[4-(1-cyanocyclopentyl)phenyl]-2-[(4-methylpyridin-3-yl)amino]pyridine-3-carboxamide methanesulfonate

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License